Loading...
Loading...
Analysts at Piper Jaffray upgraded ICU Medical
ICUI from Neutral to Overweight.
The price target for ICU Medical has been raised from $60.00 to $86.00.
ICU Medical shares have gained 15.67% over the past 52 weeks, while the S&P 500 index has surged 15.31% in the same period.
ICU Medical's shares rose 7.94% to $77.51 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in